Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
121.00
-14.00 (-10.37%)
At close: Mar 6, 2026
TYO:4596 Revenue
In the year 2025, Kubota Pharmaceutical Holdings had annual revenue of 21.34M JPY, down -20.98%. Kubota Pharmaceutical Holdings had revenue of 3.10M in the quarter ending December 31, 2025, a decrease of -68.50%.
Revenue
21.34M
Revenue Growth
-20.98%
P/S Ratio
654.51
Revenue / Employee
n/a
Employees
19
Market Cap
13.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.34M | -5.67M | -20.98% |
| Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
| Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
| Dec 31, 2022 | 8.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 7.06B |
| RaQualia Pharma | 3.98B |
| ReproCELL | 2.52B |
| Immuno-Biological Laboratories | 1.03B |
| Stella Pharma | 968.00M |
| AnGes | 874.00M |
| CellSeed | 161.00M |
| Nano Holdings | 155.00M |